Ocular Therapeutix, Inc. (OCUL): Price and Financial Metrics

OCUL POWR Grades

• Sentiment is the dimension where OCUL ranks best; there it ranks ahead of 66.2% of US stocks.
• OCUL's strongest trending metric is Quality; it's been moving down over the last 177 days.
• OCUL's current lowest rank is in the Stability metric (where it is better than 11.52% of US stocks).

OCUL Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for OCUL is 17.69 -- better than 98.21% of US stocks.
• OCUL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 81.63% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, OCULAR THERAPEUTIX INC is reporting a growth rate of 223.17%; that's higher than 93.9% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to OCULAR THERAPEUTIX INC are ASTC, CHRS, TARS, FUV, and TTOO.
• OCUL's SEC filings can be seen here. And to visit OCULAR THERAPEUTIX INC's official web site, go to www.ocutx.com.

OCUL Valuation Summary

• In comparison to the median Healthcare stock, OCUL's EV/EBIT ratio is 125.86% lower, now standing at -3.
• Over the past 112 months, OCUL's EV/EBIT ratio has gone up 10.

Below are key valuation metrics over time for OCUL.

OCUL Growth Metrics

Its year over year net income to common stockholders growth rate is now at 83.04%.
• The 4 year revenue growth rate now stands at 233.19%.
• Its 2 year price growth rate is now at -45.39%.

Over the past 33 months, OCUL's revenue has gone up $45,499,000.

The table below shows OCUL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	49.726	-57.798	-59.346
2022-06-30	49.914	-57.611	-32.501
2022-03-31	49.366	-66.791	-22.216
2021-12-31	43.522	-65.55	-6.553
2021-09-30	38.562	-56.643	-88.315
2021-06-30	32.285	-57.319	-102.916

OCUL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• OCUL has a Quality Grade of C, ranking ahead of 60.31% of graded US stocks.
• OCUL's asset turnover comes in at 0.155 -- ranking 219th of 682 Pharmaceutical Products stocks.
• CASI, ONVO, and DRNA are the stocks whose asset turnover ratios are most correlated with OCUL.

The table below shows OCUL's key quality metrics over time.